Captrust Financial Advisors Oncolytics Biotech Inc Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$0.85 - $1.59 $0 - $1	1 New	1 $0
Q1 2022 May 16, 2022	SELL	$1.31 - $2.02 $1 - $2	-1 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.39 - $2.3 $1 - $2	1 New	1 $0
Q3 2021 Nov 16, 2021	SELL	$1.93 - $2.77 $1 - $2	-1 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.6 - $4.64 $1,300 - $2,320	-500 Reduced 99.8%	1 $0
Q1 2021 May 17, 2021	BUY	$2.32 - $4.11 $1,162 - $2,059	501 New	501 $2,000
Q3 2019 Nov 14, 2019	SELL	$0.54 - $1.71 $237 - $752	-440 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$1.63 - $1.95 $717 - $858	440 New	440 $1,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $53.8M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.